Related Experiment Video
Updated: Jan 9, 2026

Multi-modal Pulmonary Imaging: Using Complementary Information from CT and Hyperpolarized 129Xe MRI to Evaluate Lung Structure-Function
Published on: April 12, 2024
Nutritional and Inflammatory Predictors of All-Cause Mortality in COPD Patients with Hypercapnic Respiratory Failure:
Zishu Zhang1, Yuexian Liu2, Zongbo Shen3
1Department of Respiratory and Critical Care Medicine, The People's Hospital of Xiangshui, Yancheng, 224600, People's Republic of China.
Background:
Patients with chronic obstructive pulmonary disease (COPD) complicated by hypercapnic respiratory failure (HRF) often have a poor prognosis. Systemic inflammation and malnutrition are associated with adverse outcomes in COPD, yet the prognostic value of nutritional/inflammatory markers remains underexplored in COPD patients with HRF.
Methods:
This prospective two-center cohort study enrolled 582 COPD complicated by HRF patients. Six indices, including Platelet-to-Lymphocyte Ratio (PLR), Neutrophil-to-Lymphocyte Ratio (NLR), Systemic Immune-Inflammation Index (SII), Prognostic Nutritional Index (PNI), Neutrophil Percentage-to-Albumin Ratio (NPAR), and Hemoglobin-Albumin-Lymphocyte-Platelet index (HALP), were calculated from admission biomarkers. Associations with 24-month all-cause mortality were evaluated using restricted cubic splines, Kaplan-Meier analysis, multivariable Cox regression, machine learning (Random Survival Forests, Boruta), threshold effect and subgroup analysis. Predictive performance was assessed via the receiver operating characteristic curve (ROC) analysis.
Results:
Over 24 months, 263 patients (45.2%) died. Non-survivors exhibited significantly higher NLR, PLR, SII, and NPAR, but lower PNI and HALP (P < 0.05). Kaplan-Meier analysis and Cox models confirmed that higher PNI (HR=0.72, 95% CI:0.54-0.96) and HALP (HR=0.55, 95% CI:0.41-0.74) were negatively correlated with all-cause mortality, while elevated PLR (HR=1.39, 95% CI:1.04-1.85), NLR (HR=1.39, 95% CI:1.02-1.88), SII (HR=1.51, 95% CI:1.11-2.05), and NPAR (HR=1.46, 95% CI:1.10-1.95) were positively correlated with all-cause mortality. For each one-standard-deviation increase in the indicators, all-cause mortality statistically significantly increased or decreased (P for trend < 0.05), with the exception of SII. Machine learning and ROC analyses consistently identified HALP, PNI, and NPAR as top predictors, with HALP demonstrating the highest importance. Subgroup analyses confirmed consistent prognostic utility for PNI, HALP, and NPAR.
Conclusion:
PNI, HALP, and NPAR are promising, readily available predictors of all-cause mortality in COPD patients with HRF, potentially enhancing risk stratification and personalized management.
More Related Videos
08:17Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
Published on: August 25, 2017
04:24Acupoint Application as a Traditional Chinese Medicine Treatment for Fatigue Associated with Chronic Obstructive Pulmonary Disease
Published on: September 5, 2025
Related Concept Videos
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation